Division of Molecular Medicine and Gene Therapy
31 – 40 of 618
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Reprogramming Stars #18 : Engineering Cell Fates and Preventing Disease by Repressing Unwanted Plasticity-An Interview with Dr. Moritz Mall
- Contribution to journal › Letter
-
Mark
MYCT1 controls environmental sensing in human haematopoietic stem cells
- Contribution to journal › Article
-
Mark
Reprogramming Stars #19 : Upgrading Cell Fate Conversions with Engineered Reprogramming Factors-An Interview with Dr. Ralf Jauch
- Contribution to journal › Article
-
Mark
Hematopoietic stem cell dynamics during regenerative stress
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance
- Contribution to journal › Article
-
Mark
Of gains and losses : SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome
- Contribution to journal › Scientific review
-
Mark
New sickle cell disease drug approved for use in England – here’s how voxelotor works
(2024) In The Conversation
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses
- Contribution to journal › Article
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
- Contribution to journal › Article
-
Mark
How to manage patients with germline DDX41 variants : Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
- Contribution to journal › Article
